As of 2024-07-27, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 47.77 mil USD. MRNS's TTM EBITDA according to its financial statements is -132.50 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 11.0x | 8.6x |
| Forward P/E multiples | 10.3x - 16.0x | 13.2x |
| Fair Price | (24.19) - (25.88) | (25.79) |
| Upside | -1791.5% - -1909.6% | -1903.7% |
| Date | EV/EBITDA |
| 2024-07-26 | -0.36 |
| 2024-07-25 | -0.35 |
| 2024-07-24 | -0.35 |
| 2024-07-23 | -0.38 |
| 2024-07-22 | -0.39 |
| 2024-07-19 | -0.36 |
| 2024-07-18 | -0.34 |
| 2024-07-17 | -0.34 |
| 2024-07-16 | -0.38 |
| 2024-07-15 | -0.35 |
| 2024-07-12 | -0.34 |
| 2024-07-11 | -0.32 |
| 2024-07-10 | -0.28 |
| 2024-07-09 | -0.29 |
| 2024-07-08 | -0.27 |
| 2024-07-05 | -0.27 |
| 2024-07-03 | -0.27 |
| 2024-07-02 | -0.26 |
| 2024-07-01 | -0.30 |
| 2024-06-28 | -0.25 |
| 2024-06-27 | -0.28 |
| 2024-06-26 | -0.29 |
| 2024-06-25 | -0.33 |
| 2024-06-24 | -0.34 |
| 2024-06-21 | -0.32 |
| 2024-06-20 | -0.33 |
| 2024-06-18 | -0.35 |
| 2024-06-17 | -0.37 |
| 2024-06-14 | -0.38 |
| 2024-06-13 | -0.37 |
| 2024-06-12 | -0.39 |
| 2024-06-11 | -0.41 |
| 2024-06-10 | -0.41 |
| 2024-06-07 | -0.40 |
| 2024-06-06 | -0.39 |
| 2024-06-05 | -0.41 |
| 2024-06-04 | -0.36 |
| 2024-06-03 | -0.38 |
| 2024-05-31 | -0.36 |
| 2024-05-30 | -0.37 |
| 2024-05-29 | -0.41 |
| 2024-05-28 | -0.39 |
| 2024-05-24 | -0.34 |
| 2024-05-23 | -0.31 |
| 2024-05-22 | -0.30 |
| 2024-05-21 | -0.32 |
| 2024-05-20 | -0.33 |
| 2024-05-17 | -0.32 |
| 2024-05-16 | -0.31 |
| 2024-05-15 | -0.32 |